160 related articles for article (PubMed ID: 38664501)
1. GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.
Shan W; Peng W; Chen Y; Wang Y; Yu Q; Tian Y; Dou Y; Tu J; Huang X; Li X; Wang Z; Zhu Q; Chen J; Xia B
Oncogene; 2024 Apr; ():. PubMed ID: 38664501
[TBL] [Abstract][Full Text] [Related]
2. Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression.
Liu T; Fan MQ; Xie XX; Shu QP; Du XH; Qi LZ; Zhang XD; Zhang MH; Shan G; Du RL; Li SZ
J Transl Med; 2023 Sep; 21(1):656. PubMed ID: 37740194
[TBL] [Abstract][Full Text] [Related]
3. A novel UCHL
Song Z; Tu X; Zhou Q; Huang J; Chen Y; Liu J; Lee S; Kim W; Nowsheen S; Luo K; Yuan J; Lou Z
Cell Death Dis; 2019 May; 10(6):398. PubMed ID: 31113933
[TBL] [Abstract][Full Text] [Related]
4. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.
Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ
Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831
[TBL] [Abstract][Full Text] [Related]
5. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
[TBL] [Abstract][Full Text] [Related]
6. UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.
Song Z; Li J; Zhang L; Deng J; Fang Z; Xiang X; Xiong J
Am J Cancer Res; 2019; 9(9):1970-1981. PubMed ID: 31598398
[TBL] [Abstract][Full Text] [Related]
7. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
8. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination.
Zhang Y; Liu JB; Liu J; Liu M; Liu HL; Zhang J
Biochem Biophys Res Commun; 2023 Jan; 641():132-138. PubMed ID: 36527747
[TBL] [Abstract][Full Text] [Related]
9. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
10. LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.
Xu LM; Yuan YJ; Yu H; Wang S; Wang P
J Transl Med; 2022 Aug; 20(1):350. PubMed ID: 35918714
[TBL] [Abstract][Full Text] [Related]
11. Circ
Xie G; Lei B; Yin Z; Xu F; Liu X
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474064
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
[TBL] [Abstract][Full Text] [Related]
13. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract][Full Text] [Related]
14. UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin.
Ma Q; Lu Q; Lei X; Zhao J; Sun W; Wang J; Zhu Q; Huang D
Front Oncol; 2023; 13():1088475. PubMed ID: 36969045
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.
Ouyang L; Yan B; Liu Y; Mao C; Wang M; Liu N; Wang Z; Liu S; Shi Y; Chen L; Wang X; Cheng Y; Cao Y; Xiao D; Zhang L; Liu S; Tao Y
Signal Transduct Target Ther; 2020 Jun; 5(1):78. PubMed ID: 32546741
[TBL] [Abstract][Full Text] [Related]
16. m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer.
Yin X; Zhao S; Zhang M; Xing J; Zhou J; Gao W; Chen L; Zhang Y; Lin L; Lu M; Li W; Shang J; Zhu X
Gynecol Oncol; 2024 Jan; 180():99-110. PubMed ID: 38086167
[TBL] [Abstract][Full Text] [Related]
17. RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.
Li H; Luo D; Huttad L; Zhang M; Wang Y; Feng J; Ding Y; Han B
Front Mol Biosci; 2021; 8():654766. PubMed ID: 34222329
[TBL] [Abstract][Full Text] [Related]
18. UCHL-3 as a potential biomarker of ovarian cancer.
Yang Q; Peng X; Nian Z; Yuan S; Wang Z; Song Y; Shamsnur R; Wang H; Yi T
Gynecol Oncol; 2024 Mar; 182():156-167. PubMed ID: 38266402
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LINC01537 Promotes Gastric Cancer Metastasis and Tumorigenesis by Stabilizing RIPK4 to Activate NF-κB Signaling.
Zhong GY; Tan JN; Huang J; Zhou SN; Yu JH; Zhong L; Hou D; Zhi SL; Zeng JT; Li HM; Zheng CL; Yang B; Han FH
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358656
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6.
Yi H; Su YZ; Lin R; Zheng XQ; Pan D; Lin DM; Gao X; Zhang R
J Immunol Res; 2021; 2021():8875450. PubMed ID: 33855091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
